BioMed Research International
Volume 2020 (2020), Article ID 9692503, 6 pages
https://doi.org/10.1155/2020/9692503

Research Article

Phosphatidylinositol-4,5-Biphosphate (PI(4,5)P₂) Is Required for Rapid Endocytosis in Chromaffin Cells

Fouad Azizi

Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar

Correspondence should be addressed to Fouad Azizi; fazizi@hamad.qa

Received 19 June 2020; Accepted 17 August 2020; Published 10 September 2020

Academic Editor: Toshiyuki Sawaguchi

Copyright © 2020 Fouad Azizi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. Phosphoinositides play a regulatory role in clathrin-mediated endocytosis. However, their involvement in clathrin-independent endocytosis termed rapid endocytosis (RE), which is the mode of vesicle recycling during neurotransmitter release by transient fusion (known as kiss-and-run), has not been investigated. Here, we used patch-clamp recording of whole-cell membrane capacitance in adrenal chromaffin cells (ACC) to monitor changes of RE kinetics in response to pharmacological alteration of phosphatidylinositol-4,5-biphosphate (PI(4,5)P₂) level by phenylarsine oxide (PAO) or antibody against phosphatidylinositol 4-kinase (AbPI4K). Results. We found that PAO and AbPI4K significantly abrogated RE kinetics. Infusion of PI(4,5)P₂ through the patch pipette potentiated RE kinetics and reversed PAO- and AbPI4K-induced blockade of RE. Similarly, the application of the bifunctional thiol dithiothreitol (DTT) to PAO-treated cells completely prevented the inhibitory effect of PAO on RE. These findings indicate that PI(4,5)P₂ is implicated in the signaling (mechanistic) process of RE in ACC.

1. Introduction

Phosphoinositides play a critical role in the nervous system functions, and their levels are normally tightly regulated by several classes of phosphoinositide kinases and phosphatases. The alteration of cellular pools of these lipids has been linked to a broad spectrum of neurological disorders (e.g., stroke, schizophrenia, bipolar disorder, and Alzheimer’s disease) [1]. Especially, phosphoinositides are known to participate extensively in vectorial membrane traffic to and from the plasma membrane mainly through clathrin-dependent endocytosis [2–4], yet their role in clathrin-independent RE has not yet being investigated.

PI(4,5)P₂ is the most abundant phosphoinositide at the inner surface of the plasma membrane where it interacts with cargo proteins leading to formation, scission, and uncoating of clathrin-coated vesicles (CCVs) [4–9] under the control of phosphoinositide kinases and phosphatases, which tightly regulate the spatio-temporal synthesis and turnover of PI(4,5)P₂ [4, 8–10]. In fact, PI(4,5)P₂ synthesis involves phosphorylation of phosphatidylinositol (PI) by several classes of PI 4-kinase (PI4K) leading to the formation of the intermediary precursor phosphatidylinositol 4-phosphate (PI4P), which undergoes phosphorylation by phosphatidylinositol-4-phosphate 5-kinase type I (PI5K) to generate PI(4,5)P₂ [3, 4, 8, 9].

RE is the clathrin-independent fast vesicle recycling process that is associated with the transient fusion (known as “kiss-and-run”) mode of neurotransmission in ACC [11–13]. RE is a highly regulated process that involves the GTPase dynamin-1 [11, 13], which is a PI(4,5)P₂-binding protein [5]. Importantly, PI(4,5)P₂ binds and promotes the insertion of dynamin into the plasma membrane, thereby facilitating the scission of CCVs from the plasma membrane [4, 6, 8, 9]. Hence, we hypothesized that PI(4,5)P₂ shall be required for RE.

In the present study, we set out to investigate the effect of PAO and anti-PI4K antibody on Ca²⁺-evoked exocytosis coupled to rapid endocytosis in ACC using patch-clamp recording of whole-cell membrane capacitance (Cm) under physiological conditions.

2. Materials and Methods

Phenylarsine oxide (P3075) and DL-dithiothreitol (D0632) were purchased from Sigma-Aldrich (Saint-Louis, MO, USA). The synthetic and water-soluble short-saturated fatty acid chain dioctanoyl phosphoinositide diC8-PI(4,5)P₂ was obtained from Echelon Biosciences (P-4508, Salt Lake City, UT). The anti-phosphatidylinositol 4 kinase III alpha antibody (AbPI4K) was from Abcam (ab111565, Cambridge, MA). Stock solutions of PAO (dissolved in DMSO at 10 mM) and DTT (dissolved in Tyrode’ solution at 50 mM) were made fresh on the day of experiments, kept in ice, and from which working solutions were made in Tyrode’ solution.

ACC were isolated by collagenase digestion of calf adrenal medullae and cultured as described previously [11, 12].

Whole-cell membrane capacitance (Cm) measurements in the standard whole-cell configuration were performed using an EPC-10 amplifier (HEKA Elektronik) as described previously [12, 14]. Briefly, Cm was evoked by a 50 mV (root mean square) sine wave at 1500 Hz using the manufacturer’s Pulse software (HEKA Elektronik). Exocytosis coupled to RE was evoked by a brief stimulation protocol that consists in applying a pulse train of 10 voltage depolarizations [8, 10]. The patch pipette contained (in mM) 100 K-glutamate, 12 NaCl, 30 HEPES, 5 MgCl₂, 2 ATP, 0.35 GTP, and 0.1 EGTA, pH adjusted to 7.2 with KOH. Ca²⁺ currents were recorded and quantitated as described [14]. The bath solution (Tyrode’ solution) consisted of (in mM) 2 CaCl₂, 10 HEPES, 10 glucose pH 7.2; 150 mM tetraethylammonium chloride and 1 μM tetrodotoxin. All experiments were performed on cell culture dishes submitted to different treatments and were carried out at room temperature (≈25°C). Parallel control dishes (untreated cells) were used on the same day.

2.1. PAO and DTT Treatment

ACC were treated with PAO (5 μM) for 5 min at 37°C in the CO₂ incubator, then 0.5 mM DTT was added to the bath solution prior to whole-cell patch-clamp capacitance recording.

2.2. AbPI4K Treatment

The antibody, dialyzed against the internal pipette solution, was loaded into the patch pipette to a final concentration of 1 mg/ml prior to whole-cell patch-clamp capacitance recording. As a control, the antibody was heat inactivated at 70°C for 20 minutes.

2.3. PI(4,5)P₂ Treatments

The phosphoinositide diC8-PI(4,5)P₂ was dissolved in the patch pipette-filling internal solution, then dialyzed against the same solution to make 1 mM stock solution stored as aliquots at −80°C. The lipid solution was sonicated for 15 min on ice prior to loading into the patch pipette at a final concentration of 100 μM.

2.4. Data Analysis

The raw data were pulled and computed from all the records. Data are expressed as the (standard error of the mean). Statistical analysis was performed by 2-sided Student’s -test. Differences between experimental conditions resulting in were considered statistically significant.

3. Results

3.1. PAO and AbPI4K Blocked Rapid Endocytosis

In an attempt to characterize the effect of PAO and AbPI4K on RE, ACC was subjected to one round of stimulation (Figure 1). The readouts of Cm changes are illustrated in Figures 1 and 2. In untreated (control) cells, depolarization-activated Ca²⁺ influx triggered a biphasic Cm response. During the first phase, the stimulation caused stepwise increases in Cm that correspond to the fusion of dense-core vesicles (DCVs) with the plasma membrane and release of catecholamines (exocytosis) (Figures 2(a) and 3(a)). This phase is immediately followed by a rapid decline in Cm due to recapture of the membrane by RE, which is completed within ≈35 sec as previously documented [11]. However, the arsenical compound PAO completely abolished RE (Figure 2(b)), resulting in unrecovered DCVs and a subsequent boost of exocytosis by 2-fold (±0.06) without affecting Ca²⁺ current (Table 1). Similarly, AbPI4K inhibited RE though not efficiently as PAO (Figure 3(c)) and consequently increased membrane capacitance (i.e., exocytosis) by 1.6-fold (±0.05) when compared to control (Table 1). Note that heat-inactivated AbPI4K did not affect RE kinetics demonstrating the specificity of the antibody (Figure 3(b)).

Figure 1: Stimulation protocol consisting of a train of 10 depolarizations, from a holding potential of −80 mV to +10 mV, each lasting 50 ms; 500 ms separated each depolarization; Each depolarization was preceded by a 50 ms prepulse to +120 mV to recruit facilitation Ca²⁺ channels [7, 8].

(a)

(b)

(c)

(d)

Figure 2: Inhibition of RE by PAO in chromaffin cells subjected to one round of stimulation. Representative whole-cell membrane capacitance (Cm) recordings from cells treated with (a) no drug (control), normal RE is seen following the exocytotic burst; (b) PAO (5 μM); (c) PAO + PI(4,5)P₂ (100 μM); (d) PAO + DTT (0.5 mM). Arrows and bars above traces indicate the timing at which the stimulation protocol was executed to elicit secretion, and the dashed lines are baselines.

(a)

(b)

(c)

(d)

Figure 3: Inhibition of RE by AbPI4K in chromaffin cells subjected to one round of stimulation. The following representative capacitance (Cm) traces correspond to (a) untreated cells (control); (b) Heat-inactivated AbPI4K (1 mg/ml); (c) AbPI4K (1 mg/ml); (d) AbPI4K + PI(4,5)P₂. Arrows and bars above traces indicate the timing at which the stimulation protocol was executed to elicit secretion, and the dashed lines are baselines.

Table 1: Statistical analysis of rapid endocytosis parameters in chromaffin cells.

Treatment
Cm increase (fF)
RE duration (sec)
Peak current (pA)
Cumulative current integral (pC)

Control ()

PAO ()

—

AbPI4K ()

—

PI(4,5)P₂ ()

PAO + PI(4,5)P₂
(n =19)

AbPI4K + PI(4,5)P₂ ()

PAO + DTT ()

Whole-cell membrane capacitance (Cm) records of exocytosis and rapid endocytosis (RE) were acquired and analyzed according to our previously described methods [7, 8]. Total Cm increase and total Cm decrease correspond respectively to the maximum increase and the maximum decrease of Cm induced by voltage depolarization (see Materials & Methods). The duration of RE is the time required for Cm to return to baseline from the maximum level after stimulation (, , significantly different from control). Peak current corresponds to the maximum Ca²⁺ current amplitude evoked by the first pulse in the train of stimulation. Cumulative current integral is calculated from the total number of Ca²⁺ ions entering the cell during the entire stimulation period (10 depolarizations of 50 ms).

3.2. PI(4,5)P₂ Rescued Inhibition of Rapid Endocytosis by PAO and AbPI4K

In ACC, the inhibition of PI4K enzymatic function by AbPI4K or PAO is expected to substantially reduce the endogenous level of PI(4)P, which is needed for replenishment of plasma membrane PI(4,5)P₂ [3, 15]. Hence, we reasoned that the introduction of exogenous PI(4,5)P₂ into ACC via the patch pipette would be a good strategy to counteract the inhibitory action of PAO and AbPI4K on RE. Notably, infusing PI(4,5)P₂ into untreated patched ACC submitted to one round of stimulation enhanced RE by 2-fold (±0.04) in comparison to control (Table 1), indicating that fine-tuning of cellular PI(4,5)P₂ level (turnover) regulates vesicle recycling and replenishment rate of the secretory pools. Repeating such maneuver in ACC treated with PAO resulted in membrane (vesicle) retrieval albeit with slower kinetics compared to control (Figure 1(c), Table 1). In contrast, exogenous PI(4,5)P₂ completely rescued RE in cells treated with AbPI4K (Figure 2(d)), indicating that PI(4,5)P₂ is required for RE. Evoked secretion and Ca²⁺ current remained intact mirroring control conditions (Table 1).

3.3. DTT Prevented Inhibition of Rapid Endocytosis by PAO

The mechanism by which PAO reacts with biological molecules and inhibits certain enzymatic processes involves crosslinking their vicinal sulfhydryl groups with the arsenic atom to form a stable ring complex that can be reversed with a stoichiometric amount of a vicinal dithiol compound, such as DTT [16]. Indeed, the addition of DTT in the bath solution averted the inhibitory effect of PAO on RE (Figure 1(d)). Cm measurements revealed that secretion and Ca²⁺ current were not affected by DTT, and the kinetics of RE were very similar to control conditions (Table 1).

4. Discussion

To our knowledge, this is the first whole-cell membrane capacitance (Cm) patch-clamp electrophysiological study to use PAO and AbPI4K as pharmacological blockers in order to investigate the potential role of phosphoinositides in RE. In ACC, one round of exocytosis coupled to rapid endocytosis was evoked by a physiological stimulation protocol that has been designed specifically for recruiting facilitation L-type Ca²⁺ channels, which are so closely linked to secretory sites [17, 18]. Blocking these channels would of course block the whole process of secretion but none of the drugs affected the Ca²⁺ current (cumulative current integral), which was very similar in the different experimental conditions (Table 1). Interestingly, PAO at 100 μM was found to transiently stimulate basal L-type Ca²⁺ current in cardiomyocytes [19]. In contrast, at motor nerve endings of neuromuscular junctions, PAO at 30 μM was shown to inhibit Ca²⁺ entry via N-type Ca²⁺ channels [20], but this type of channels contributes little to evoked secretion in chromaffin cells [17, 18].

PAO, a sulfhydryl (SH)-reactive agent, has been widely used to investigate the role of PI(4,5)P₂ in intracellular anterograde and retrograde vesicular transport as this trivalent arsenical chemical blocks PI4K activity and thereby reduces PI4P and PI(4,5)P₂ levels [3, 15, 16, 21]. In particular, PAO was shown to block clathrin-dependent endocytosis through the depletion of plasma membrane PI(4,5)P₂ [22]. In chromaffin cells [15] and isolated synaptosomes [21], PAO was found to reduce catecholamine secretion through the inactivation of PI4K and concomitant loss of PI(4)P and PI(4,5)P₂ pools. In this study, we show that PAO exhibited an inhibitory effect on the rapid clathrin-independent endocytosis without affecting exocytosis.

At low micromolar concentrations, PAO inhibits the type-IIIα isoform of PI 4-kinase (PI4K230), which is considered the main lipid-kinase responsible for the generation of plasma membrane phosphoinositides [16]. Furthermore, the effect of PAO treatment on plasma membrane PI4P and PI(4,5)P₂ has been demonstrated using the biosensors of these lipids [3, 23, 24].

The complete abolition of RE induced by PAO but not by the anti-PI4K type III-α (PI4K230) antibody is likely due to the ability of PAO to target other PI4K isoforms [15, 16, 24]. For example, PAO was found to target the chromaffin granule-associated PI4K55 (PI4K type II-α) [15, 24]) resulting in the attenuation of Ca²⁺-stimulated neurotransmitter release due to reduced levels of both phosphoinositides PI4P and PI(4,5)P₂ in permeabilized ACC [15] and isolated synaptosomes [21, 25]. Therefore, the residual endocytosis observed with AbPI4K may be due to the activity of other PI4K isoforms. A deeper investigation with specific inhibitors of PI4k isoforms would confirm the results found with PAO and AbPI4K and identify which PI4k isoforms are implicated in RE.

Loading ACC with exogenous PI(4,5)P₂ superseded AbPI4K- and PAO-evoked inhibition of RE. Similarly, the disulfide-reducing chemical agent DTT, which was found to reinstate endogenous PI4P and PI(4,5)P₂ to their normal levels in PAO-treated ACC [15], completely restored RE. Therefore, PI(4,5)P₂ is required for the fast recycling of DCVs and replenishing of the secretory pools for subsequent rounds of secretion.

5. Conclusions

In conclusion, we used two functional assays to provide proof of concept that PI(4,5)P₂ is involved in the signaling of clathrin-independent rapid endocytosis associated with transient fusion of vesicles, which is a neurotransmission mode manifested in hippocampal neurons undergoing bursting patterns of activity implicated in tasks and activities such as memory formation [26]. We propose that PI(4,5)P₂ may function in RE by facilitating assembly of dynamin-1 molecules [8, 9, 27] after their insertion into the plasma membrane [4–6, 8, 9]. The interaction of PI(4,5)P₂ with the Pleckstrin homology domain (PH domain) of dynamin-1 would result in adequate stimulation of its intrinsic GTPase activity [8, 9, 27, 28] and consequently lead to efficient pinching off of endocytic vesicles. Evidence for such scenario has been already shown in pancreatic β cells where PI(4,5)P₂ was found to promote DCVs kiss-and-run mode of insulin secretion [29]. Nevertheless, phosphatidylinositol-3,4-bisphosphate (PI(3,4)P₂) is another important signaling lipid that is mechanistically involved in both clathrin-dependent endocytosis [6, 8, 30, 31] and clathrin-independent fast endophilin-mediated endocytosis (FEME) [31]. Indirect conversion of PI(4,5)P₂ to PI(3,4)P₂ is required during the late stage of the endocytic process in order to recruit PI(3,4)P₂ effectors at endocytic sites and trigger vesicle scission and recycling by dynamin [6, 8, 30]. Therefore, PI(3,4)P₂ and its effectors merit attention and investigation in RE. Future studies using double patch-clamp electrophysiology, which is based on combining whole-cell and cell-attached configurations [12], would reinforce our results and certainly shed more light on whether these phosphoinositides modulate neurotransmitter release by regulating fusion pore dynamics during individual secretory events in ACC. Additional work analyzing RE in cells transfected with mutants of the phosphatidylinositol 4-kinase (PI4K) isoforms would strengthen the findings of this study and identify the major PI4K involved in RE.

Abbreviations

PI4P: | Phosphatidylinositol 4-phosphate
PI(4,5)P₂: | Phosphatidylinositol-4,5-biphosphate
PI(3,4)P₂: | Phosphatidylinositol-3,4-bisphosphate
RE: | Rapid endocytosis
Cm: | Whole-cell membrane capacitance
ACC: | Adrenal chromaffin cells
PAO: | Phenylarsine oxide
DTT: | Dithiothreitol
PI: | Phosphatidylinositol
PI4K: | Phosphatidylinositol 4-kinase
PI5K: | Phosphatidylinositol-4-phosphate 5-kinase
CCVs: | Clathrin-coated vesicles
DCVs: | Dense core vesicles
AbPI4K: | Antibody against phosphatidylinositol 4-kinase.

Data Availability

All data generated or analyzed during this study are included in this published article.

Conflicts of Interest

The author declares that he has no competing interests.

Acknowledgments

This study was supported by the Medical Research Center grant number 15349/15 from Hamad Medical Corporation, Qatar. The publication of this article is supported by the Qatar National Library.

References

M. G. Waugh, “PIPs in neurological diseases,” Biochimica et Biophysica Acta, vol. 1851, no. 8, pp. 1066–1082, 2015.

G. Di Paolo and P. De Camilli, “Phosphoinositides in cell regulation and membrane dynamics,” Nature, vol. 443, no. 7112, pp. 651–657, 2006.

G. R. V. Hammond, M. J. Fischer, K. E. Anderson et al., “PI4P and PI(4,5)P2 are essential but independent lipid determinants of membrane identity,” Science, vol. 337, no. 6095, pp. 727–730, 2012.

A. Simonsen, A. E. Wurmser, S. D. Emr, and H. Stenmark, “The role of phosphoinositides in membrane transport,” Current Opinion in Cell Biology, vol. 13, no. 4, pp. 485–492, 2001.

V. Haucke, “Phosphoinositide regulation of clathrin-mediated endocytosis,” Biochemical Society Transactions, vol. 33, no. 6, pp. 1285–1289, 2005.

V. Haucke and M. M. Kozlov, “Membrane remodeling in clathrin-mediated endocytosis,” Journal of Cell Science, vol. 131, no. 17, article jcs216812, 2018.

G. R. Hammond and T. Balla, “Polyphosphoinositide binding domains: Key to inositol lipid biology,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1851, no. 6, pp. 746–758, 2015.

Y. Posor, M. Eichhorn-Grünig, and V. Haucke, “Phosphoinositides in endocytosis,” Biochimica et Biophysica Acta, vol. 2015, pp. 794–804, 2015.

T. Balla, “Phosphoinositides: tiny lipids with giant impact on cell regulation,” Physiological Reviews, vol. 93, no. 3, pp. 1019–1137, 2013.

R. L. Doughman, A. J. Firestone, and R. A. Anderson, “Phosphatidylinositol phosphate kinases put PI4,5P 2 in its place,” The Journal of Membrane Biology, vol. 194, no. 2, pp. 77–89, 2003.

C. R. Artalejo, J. R. Henley, M. A. Mcniven, and H. C. Palfrey, “Rapid endocytosis coupled to exocytosis in adrenal chromaffin cells involves Ca²⁺, GTP, and dynamin but not clathrin,” Proceedings of the National Academy of Sciences, vol. 92, no. 18, pp. 8328–8332, 1995.

A. Elhamdani, F. Azizi, and C. R. Artalejo, “Double patch clamp reveals that transient fusion (kiss-and-run) is a major mechanism of secretion in calf adrenal chromaffin cells: high calcium shifts the mechanism from kiss-and-run to complete fusion,” The Journal of Neuroscience, vol. 26, no. 11, pp. 3030–3036, 2006.

T. Fulop, B. Doreian, and C. Smith, “Dynamin I plays dual roles in the activity-dependent shift in exocytic mode in mouse adrenal chromaffin cells,” Archives of Biochemistry and Biophysics, vol. 477, no. 1, pp. 146–154, 2008.

C. R. Artalejo, A. Elhamdani, and H. C. Palffrey, “Calmodulin is the divalent cation receptor for rapid endocytosis, but not exocytosis, in adrenal chromaffin cells,” Neuron, vol. 16, no. 1, pp. 195–205, 1996.

C. Wiedemann, T. Schafer, and M. M. Burger, “Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion,” The EMBO Journal, vol. 15, no. 9, pp. 2094–2101, 1996.

A. Balla, Y. J. Kim, P. Varnai et al., “Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIα,” Molecular Biology of the Cell, vol. 19, no. 2, pp. 711–721, 2008.

C. R. Artalejo, M. E. Adams, and A. P. Fox, “Three types of Ca²⁺ channel trigger secretion with different efficacies in chromaffin cells,” Nature, vol. 367, no. 6458, pp. 72–76, 1994.

C. R. Artalejo, S. Rossie, R. L. Perlman, and A. P. Fox, “Voltage-dependent phosphorylation may recruit Ca²⁺ current facilitation in chromaff in cells,” Nature, vol. 358, no. 6381, pp. 63–66, 1992.

C. Sims and R. D. Harvey, “Redox modulation of basal andβ-adrenergically stimulated cardiac L-type Ca2+channel activity by phenylarsine oxide,” British Journal of Pharmacology, vol. 142, no. 4, pp. 797–807, 2004.

T. J. Searl and E. M. Silinsky, “The phosphatidylinositol 4-kinase inhibitor phenylarsine oxide blocks evoked neurotransmitter release by reducing calcium entry through N-type calcium channels,” British Journal of Pharmacology, vol. 130, no. 2, pp. 418–424, 2000.

M. Khvotchev and T. C. Sϋdhof, “Newly synthesized phosphatidylinositol phosphates are required for synaptic norepinephrine but not glutamate or γ-aminobutyric acid (GABA) release,” Journal of Biological Chemistry, vol. 273, no. 34, pp. 21451–21454, 1998.

S.-H. Lee, J. Shim, S.-L. Choi et al., “Learning-related synaptic growth mediated by internalization of Aplysia cell adhesion molecule is controlled by membrane phosphatidylinositol 4,5-bisphosphate synthetic pathway,” The Journal of Neuroscience, vol. 32, no. 46, pp. 16296–16305, 2012.

G. R. V. Hammond, G. Schiavo, and R. F. Irvine, “Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P2,” The Biochemical Journal, vol. 422, no. 1, pp. 23–35, 2009.

H. L. Olsen, M. Hoy, W. Zhang et al., “Phosphatidylinositol 4-kinase serves as a metabolic sensor and regulates priming of secretory granules in pancreatic β cells,” Proceedings of the National Academy of Sciences, vol. 100, no. 9, pp. 5187–5192, 2003.

Q. Zheng, S. C. McFadden, and J. A. Bobich, “Phosphatidylinositol 4,5-bisphosphate promotes both [3H]-noradrenaline and [14C]-glutamate exocytosis from nerve endings,” Neurochemistry International, vol. 44, no. 4, pp. 243–250, 2004.

N. C. Harata, A. M. Aravanis, and R. W. Tsien, “Kiss-and-run and full-collapse fusion as modes of exo-endocytosis in neurosecretion,” Journal of Neurochemistry, vol. 97, no. 6, pp. 1546–1570, 2006.

B. Antonny, C. Burd, P. De Camilli et al., “Membrane fission by dynamin: what we know and what we need to know,” The EMBO Journal, vol. 35, no. 21, pp. 2270–2284, 2016.

K. Salim, M. J. Bottomley, E. Querfurth et al., “Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase,” The EMBO Journal, vol. 15, no. 22, pp. 6241–6250, 1996.

Y. Xu, D. K. Toomre, J. S. Bogan, and M. Hao, “Excess cholesterol inhibits glucose-stimulated fusion pore dynamics in insulin exocytosis,” Journal of Cellular and Molecular Medicine, vol. 21, no. 11, pp. 2950–2962, 2017.

Y. Posor, M. Eichhorn-Gruenig, D. Puchkov et al., “Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate,” Nature, vol. 499, no. 7457, pp. 233–237, 2013.

L. Gozzelino, M. C. De Santis, F. Gulluni, E. Hirsch, and M. Martini, “PI(3,4)P2 Signaling in Cancer and Metabolism,” Frontiers in Oncology, vol. 10, p. 360, 2020.